Skip to main content
. 2021 Aug 13;100(32):e26962. doi: 10.1097/MD.0000000000026962

Figure 3.

Figure 3

Flowchart of the study. RC, 0.5% ropivacaine; RD, 0.5% ropivacaine, and 1 μg/kg dexmedetomidine; RN, 0.5% ropivacaine and 20 mg nabluphine.